{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T17:25:18Z","timestamp":1778433918099,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00210-019-01759-3","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T11:03:08Z","timestamp":1574766188000},"page":"615-627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effects of single and dual RAAS blockade therapy on progressive kidney disease transition to CKD in rats"],"prefix":"10.1007","volume":"393","author":[{"given":"Devesh","family":"Aggarwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaaminepreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,26]]},"reference":[{"key":"1759_CR1","doi-asserted-by":"crossref","unstructured":"Aebi H (1974) Catalase. In: Methods of enzymatic analysis. Elsevier, pp 673\u2013684","DOI":"10.1016\/B978-0-12-091302-2.50032-3"},{"key":"1759_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/ki.2012.352","volume":"83","author":"J Barrera-Chimal","year":"2013","unstructured":"Barrera-Chimal J, P\u00e9rez-Villalva R, Rodr\u00edguez-Romo R, Reyna J, Uribe N, Gamba G, Bobadilla NA (2013) Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury. Kidney Int 83:93\u2013103. https:\/\/doi.org\/10.1038\/ki.2012.352","journal-title":"Kidney Int"},{"key":"1759_CR3","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/ndt\/gfy246","volume":"34","author":"J Barrera-Chimal","year":"2019","unstructured":"Barrera-Chimal J, Rocha L, Amador-Mart\u00ednez I et al (2019) Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation. Nephrol Dial Transplant 34:794\u2013801. https:\/\/doi.org\/10.1093\/ndt\/gfy246","journal-title":"Nephrol Dial Transplant"},{"key":"1759_CR4","doi-asserted-by":"publisher","first-page":"F887","DOI":"10.1152\/ajprenal.00050.2001","volume":"281","author":"DP Basile","year":"2001","unstructured":"Basile DP, Donohoe D, Roethe K, Osborn JL (2001) Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol-Ren Physiol 281:F887\u2013F899. https:\/\/doi.org\/10.1152\/ajprenal.00050.2001","journal-title":"Am J Physiol-Ren Physiol"},{"key":"1759_CR5","doi-asserted-by":"publisher","first-page":"F1494","DOI":"10.1152\/ajprenal.00691.2011","volume":"302","author":"DP Basile","year":"2012","unstructured":"Basile DP, Leonard EC, Beal AG et al (2012) Persistent oxidative stress following renal ischemia-reperfusion injury increases ANG II hemodynamic and fibrotic activity. Am J Physiol-Ren Physiol 302:F1494\u2013F1502. https:\/\/doi.org\/10.1152\/ajprenal.00691.2011","journal-title":"Am J Physiol-Ren Physiol"},{"key":"1759_CR6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1053\/j.ajkd.2011.09.010","volume":"59","author":"M Bedford","year":"2012","unstructured":"Bedford M, Farmer C, Levin A, Ali T, Stevens P (2012) Acute kidney injury and CKD: chicken or egg? Am J Kidney Dis 59:485\u2013491. https:\/\/doi.org\/10.1053\/j.ajkd.2011.09.010","journal-title":"Am J Kidney Dis"},{"key":"1759_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1053\/j.ajkd.2007.10.040","volume":"51","author":"AS Bomback","year":"2008","unstructured":"Bomback AS, Kshirsagar AV, Amamoo MA et al (2008) Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review. Am J Kidney Dis 51:199\u2013211","journal-title":"Am J Kidney Dis"},{"key":"1759_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/0003-2697(72)90335-1","volume":"46","author":"AF Boyne","year":"1972","unstructured":"Boyne AF, Ellman GL (1972) A methodology for analysis of tissue sulfhydryl components. Anal Biochem 46:639\u2013653. https:\/\/doi.org\/10.1016\/0003-2697(72)90335-1","journal-title":"Anal Biochem"},{"key":"1759_CR9","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/ki.2012.208","volume":"82","author":"LS Chawla","year":"2012","unstructured":"Chawla LS, Kimmel PL (2012) Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int 82:516\u2013524","journal-title":"Kidney Int"},{"key":"1759_CR10","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/S0735-1097(01)01237-2","volume":"37","author":"M Cicoira","year":"2001","unstructured":"Cicoira M, Zanolla L, Rossi A, Golia G, Franceschini L, Cabrini G, Bonizzato A, Graziani M, Anker SD, Coats AJ, Zardini P (2001) Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype. J Am Coll Cardiol 37:1808\u20131812","journal-title":"J Am Coll Cardiol"},{"key":"1759_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/ki.2011.379","volume":"81","author":"SG Coca","year":"2012","unstructured":"Coca SG, Singanamala S, Parikh CR (2012) Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 81:442\u2013448","journal-title":"Kidney Int"},{"key":"1759_CR12","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/ki.1991.138","volume":"39","author":"JD Conger","year":"1991","unstructured":"Conger JD, Robinette JB, Hammond WS (1991) Differences in vascular reactivity in models of ischemic acute renal failure. Kidney Int 39:1087\u20131097. https:\/\/doi.org\/10.1038\/ki.1991.138","journal-title":"Kidney Int"},{"key":"1759_CR13","doi-asserted-by":"publisher","first-page":"R922","DOI":"10.1152\/ajpregu.1999.277.3.R922","volume":"277","author":"KK Donnahoo","year":"1999","unstructured":"Donnahoo KK, Meng X, Ayala A et al (1999) Early kidney TNF-\u03b1 expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol-RegulIntegr Comp Physiol 277:R922\u2013R929. https:\/\/doi.org\/10.1152\/ajpregu.1999.277.3.R922","journal-title":"Am J Physiol-RegulIntegr Comp Physiol"},{"issue":"11","key":"1759_CR14","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1681\/ASN.V12112370","volume":"12","author":"PA Glynne","year":"2001","unstructured":"Glynne PA, Picot J, Evans TJ (2001) Co expressed nitric oxide synthase and apical beta(1) integrins influence tubule cell adhesion after cytokine-induced injury. J Am Soc Nephrol 12(11):2370\u20132383","journal-title":"J Am Soc Nephrol"},{"key":"1759_CR15","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/ki.2011.413","volume":"81","author":"JA Hirst","year":"2012","unstructured":"Hirst JA, Taylor KS, Stevens RJ et al (2012) The impact of renin\u2013angiotensin\u2013aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy. Kidney Int 81:674\u2013683","journal-title":"Kidney Int"},{"issue":"3","key":"1759_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/ALN.0b013e318164cff8","volume":"108","author":"R Hirose","year":"2008","unstructured":"Hirose R, Xu F, Dang K, Liu T, Behrends M, Brakeman PR, Wiener-Kronish J, Niemann CU (2008) Transient hyperglycemia affects the extent of ischemia-reperfusion-induced renal injury in rats. Anaesthesiology 108(3):402\u2013414","journal-title":"Anaesthesiology"},{"key":"1759_CR17","doi-asserted-by":"publisher","first-page":"e96353","DOI":"10.1371\/journal.pone.0096353","volume":"9","author":"M Ivanov","year":"2014","unstructured":"Ivanov M, Mihailovi\u0107-Stanojevi\u0107 N, Gruji\u0107 Milanovi\u0107 J et al (2014) Losartan improved antioxidant defense, renal Function and structure of Postischemic Hypertensive Kidney. PLoS ONE 9:e96353. https:\/\/doi.org\/10.1371\/journal.pone.0096353","journal-title":"PLoS ONE"},{"key":"1759_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/ki.2008.128","volume":"74","author":"JA Jefferson","year":"2008","unstructured":"Jefferson JA, Shankland SJ, Pichler RH (2008) Proteinuria in diabetic kidney disease: a mechanistic viewpoint. Kidney Int 74:22\u201336. https:\/\/doi.org\/10.1038\/ki.2008.128","journal-title":"Kidney Int"},{"key":"1759_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cccn.2004.02.007","volume":"344","author":"W Junge","year":"2004","unstructured":"Junge W, Wilke B, Halabi A, Klein G (2004) Determination of reference intervals for serum creatinine, creatinine excretion and creatinine clearance with an enzymatic and a modified Jaff\u00e9 method. Clin Chim Acta 344:137\u2013148. https:\/\/doi.org\/10.1016\/j.cccn.2004.02.007","journal-title":"Clin Chim Acta"},{"key":"1759_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/ndt\/gfn448","volume":"24","author":"YS Kang","year":"2008","unstructured":"Kang YS, Ko GJ, Lee MH et al (2008) Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats. Nephrol Dial Transplant 24:73\u201384. https:\/\/doi.org\/10.1093\/ndt\/gfn448","journal-title":"Nephrol Dial Transplant"},{"key":"1759_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4093\/dmj.2011.35.2.130","volume":"35","author":"MY Lee","year":"2011","unstructured":"Lee MY, Shim MS, Kim BH et al (2011) Effects of spironolactone and losartan on diabetic nephropathy in a type 2 diabetic rat model. Diabetes Metab J 35:130. https:\/\/doi.org\/10.4093\/dmj.2011.35.2.130","journal-title":"Diabetes Metab J"},{"key":"1759_CR22","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.3390\/jcm4111908","volume":"4","author":"L Lozano-Maneiro","year":"2015","unstructured":"Lozano-Maneiro L, Puente-Garc\u00eda A (2015) Renin-angiotensin-aldosterone system blockade in diabetic nephropathy. Present Evidences J Clin Med 4:1908\u20131937. https:\/\/doi.org\/10.3390\/jcm4111908","journal-title":"Present Evidences J Clin Med"},{"key":"1759_CR23","doi-asserted-by":"publisher","unstructured":"Malek M (2015) Renal ischemia\/reperfusion injury; from pathophysiology to treatment. J Renal. Inj Prev. https:\/\/doi.org\/10.12861\/jrip.2015.06","DOI":"10.12861\/jrip.2015.06"},{"key":"1759_CR24","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2215\/CJN.05300516","volume":"12","author":"M Medeiros","year":"2017","unstructured":"Medeiros M, Vel\u00e1squez-Jones L, Hern\u00e1ndez AM, Ram\u00f3n-Garc\u00eda G, Valverde S, Fuentes Y, Vargas A, Pati\u00f1o M, P\u00e9rez-Villalva R, Ortega-Trejo JA, Barrera-Chimal J, Bobadilla NA (2017) Randomized controlled trial of mineralocorticoid receptor blockade in children with chronic kidney allograft nephropathy. Clin J Am Soc Nephrol 12:1291\u20131300. https:\/\/doi.org\/10.2215\/CJN.05300516","journal-title":"Clin J Am Soc Nephrol"},{"key":"1759_CR25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351\u2013358. https:\/\/doi.org\/10.1016\/0003-2697(79)90738-3","journal-title":"Anal Biochem"},{"issue":"5","key":"1759_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1464-5491.2004.01194.x","volume":"21","author":"R Rachmani","year":"2004","unstructured":"Rachmani R, Slavachevsky I, Amit M et al (2004) The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study. Diabet Med 21(5):471\u2013475","journal-title":"Diabet Med"},{"key":"1759_CR27","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1097\/01.ASN.0000096784.86791.21","volume":"14","author":"E Ritz","year":"2003","unstructured":"Ritz E (2003) Angiotensin II and oxidative stress: an unholy alliance. J Am Soc Nephrol 14:2985\u20132987. https:\/\/doi.org\/10.1097\/01.ASN.0000096784.86791.21","journal-title":"J Am Soc Nephrol"},{"key":"1759_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/ki.2015.320","volume":"89","author":"R Rodr\u00edguez-Romo","year":"2016","unstructured":"Rodr\u00edguez-Romo R, Ben\u00edtez K, Barrera-Chimal J, P\u00e9rez-Villalva R, G\u00f3mez A, Aguilar-Le\u00f3n D, Rangel-Santiago JF, Huerta S, Gamba G, Uribe N, Bobadilla NA (2016) AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease. Kidney Int 89:363\u2013373. https:\/\/doi.org\/10.1038\/ki.2015.320","journal-title":"Kidney Int"},{"key":"1759_CR29","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1681\/ASN.2006040356","volume":"17","author":"C R\u00fcster","year":"2006","unstructured":"R\u00fcster C, Wolf G (2006) Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol 17:2985\u20132991. https:\/\/doi.org\/10.1681\/ASN.2006040356","journal-title":"J Am Soc Nephrol"},{"key":"1759_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/147323000102900103","volume":"29","author":"A Sato","year":"2001","unstructured":"Sato A, Saruta T (2001) Aldosterone escape during angiotensin converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy. J Int Med Res 29:13\u201321. https:\/\/doi.org\/10.1177\/147323000102900103","journal-title":"J Int Med Res"},{"issue":"12","key":"1759_CR31","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1093\/clinchem\/14.12.1160","volume":"14","author":"J Savory","year":"1968","unstructured":"Savory J, Pu PH, Sunderman FW (1968) A biuret method for determination of protein in normal urine. Clin Chem 14(12):1160\u20131171","journal-title":"Clin Chem"},{"issue":"11","key":"1759_CR32","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1007\/s00125-004-1542-0","volume":"47","author":"KJ Schjoedt","year":"2004","unstructured":"Schjoedt KJ, Andersen S, Rossing P, Tarnow L, Parving HH (2004) Aldosterone escape during blockade of the renin\u2013angiotensin\u2013aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate. Diabetologia 47(11):1936\u20131939","journal-title":"Diabetologia"},{"key":"1759_CR33","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00210-018-1511-7","volume":"391","author":"G Singh","year":"2018","unstructured":"Singh G, Krishan P (2018) Cobalt treatment does not prevent glomerular morphological alterations in type 1 diabetic rats. Naunyn Schmiedebergs Arch Pharmacol 391:933\u2013944. https:\/\/doi.org\/10.1007\/s00210-018-1511-7","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"1759_CR34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1677\/joe.0.0910457","volume":"91","author":"J Staessen","year":"1981","unstructured":"Staessen J, Lijnen P, Fagard R (1981) Rise in plasma concentration of aldosterone during long-term angiotensin II suppression. J Endocrinol 91(3):457\u2013465","journal-title":"J Endocrinol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-019-01759-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-019-01759-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-019-01759-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T23:05:38Z","timestamp":1665097538000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-019-01759-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,26]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1759"],"URL":"https:\/\/doi.org\/10.1007\/s00210-019-01759-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,26]]},"assertion":[{"value":"13 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"All procedures performed in studies involving animals were in accordance with the ethical standards of the ISF College of Pharmacy, Moga, Punjab, India (ISFCP\/IAEC\/CPCSEA\/Meeting No. 23\/2018\/Protocol No. 371).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}